JHS Svendgaard Laboratories Limited (JHS) — Board Meeting | 25 June 2026

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

The Board of JHS Svendgaard Laboratories approved a shareholder-approved variation in the utilization of proceeds from its preferential issue, modifying the original allocation of funds to extend timelines to March 31, 2027 and clarify broader use of capital for business expansion, strategic initiatives, and corporate purposes, while retaining the total amount of ₹2,999.99 lakhs.

📄 View Original Announcement (PDF)

About JHS Svendgaard Laboratories Limited (JHS)

Fast Moving Consumer Goods · FMCG · Listed on NSE

Market Cap: ₹68.44 Cr ROE: -1.1% ROCE: -1.1%

View full JHS stock details →

📡 Get AI alerts when JHS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track JHS — Free

📊 More JHS filings

See all JHS filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when JHS files new disclosures

Track JHS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track JHS — Free

Free account · 2 AI queries/day